Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Octreotide acetate (oral use)

EU orphan designation number: EU/3/13/1170   
Active ingredient: Octreotide acetate (oral use)
Indication: Treatment of acromegaly
Sponsor: Larode Ltd
Rhode Farm, Priory Lane, Selborne, Hampshire GU34 3BU, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/08/2013 Orphan designation EMA/OD/042/13 (2013)5270 of 05/08/2013
25/09/2014 Change of name and/or address of sponsor